[Nab-Paclitaxel with platinum chemotherapy as sixth-line therapy for a non-small cell lung cancer patient]

Yoshihisa Ishiura; Yasutaka Shiba; Yasushi Terasaki; Yoshinobu Hinoue; Youichi Ishida; Masataka Segawa; Katsuhiko Saitoh; Norikazu Hirokami; Kazuo Kasahara; Masaki Fujimura

[Nab-Paclitaxel with platinum chemotherapy as sixth-line therapy for a non-small cell lung cancer patient]

Gan To Kagaku Ryoho. 2015 Apr;42(4):493-5.

[Article in Japanese]

Authors

Yoshihisa Ishiura¹, Yasutaka Shiba, Yasushi Terasaki, Yoshinobu Hinoue, Youichi Ishida, Masataka Segawa, Katsuhiko Saitoh, Norikazu Hirokami, Kazuo Kasahara, Masaki Fujimura

Affiliation

¹ Dept. of Medical Oncology, Toyama City Hospital.

PMID: 25963700

Abstract

A 48-year-old woman was admitted to our hospital for sixth-line chemotherapy. A chest X-ray film and computed tomographic (CT) scan revealed a right-sided massive tumor with multiple lung tumors. Repeated treatment with carboplatin (AUC 6) on day 1 and nab-paclitaxel (100mg/m2) on days 1, 8, and 15, every 28 days were effective in this patient. Chemotherapy with nab-paclitaxel may be effective for patients with multi-recurrent adenocarcinoma.

Publication types

Case Reports
English Abstract

MeSH terms

Adenocarcinoma / drug therapy*
Albumins / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Carboplatin / administration & dosage
Carcinoma, Non-Small-Cell Lung / drug therapy*
Female
Humans
Lung Neoplasms / drug therapy*
Lung Neoplasms / pathology
Middle Aged
Paclitaxel / administration & dosage

Substances

130-nm albumin-bound paclitaxel
Albumins
Carboplatin
Paclitaxel